2Q EARNINGS: Sanofi starts 'R&D story' and beats expectations
This article was originally published in Scrip
Executive Summary
Sanofi has raised its full-year profit forecast as it posted stronger than expected second quarter results, driven by its Genzyme unit and higher sales in emerging markets.